The ScanBalt Clinical Research Network project, launched in March 2005, was successfully finished in April 2006. The ScanBalt Clinical Research Network was a pilot project, funded by Nordic innovation Center, which overall aim was to give added value to the vision of ScanBalt BioRegion: to be a globally competitive meta-region. Two main objectives of the project were:
1. to map the resources and competencies of clinical research in the region;
2. to identify the persons for continued activities in the network.
As a result of the project completed mapping of competencies and resources in the field of pre-clinical research, clinical trials, and mobile ICT solutions for conducting clinical trials was carried out. Based on this a database with search engine for competencies and partners was created (available at www.scanbalt.org/factfile-c). The general result of the project indicated that all parties involved found the clinical network important and useful. On the other hand it was not easy to find persons that are willing to take active role in setting up really working network. Substantial efforts and financial resources are needed in order create a fully working network structure. CRO-s seems to have a theoretical conflict of interest as investigator network are often main proprietary asset of the company.
Nevertheless, it has been widely recognized the ScanBalt Bioregion countries and regions to be too small on their own to be able to supply large enough trial groups. Number of governments (for example UK) has initiated strategic projects to improve their position on the global clinical research arena. Mutual cooperation based on the well organized network will potentially improve ScanBalt Bioregions position in clinical research industry.
The vision of the follow-up proof of concept project to the ScanBalt Clinical Research Network pilot project is to set up a working patient recruitment network in the ScanBalt region embracing one disease area - diabetes. The new organization will be based on the interconnection network of academic clinical research infrastructures, hospitals and industry.
This diabetes network has to provide effective and efficient infrastructure for prompt recruitment and clinical trial management: legally and organizationally sound tool for electronic selection of patients from different clinical databases and research sites, efficient system for obtaining approvals by ethics committees and obtaining informed consent from participants, appropriate management IT tool for conducting clinical trials and securing the quality of trials.
The Estonian Genome Project Foundation in cooperation with Tartu Biotechnology Park and Sahlgrenska University Hospital has started to select partners as well to design general outline for this proof of principle project. The proof of concept project, if successful, can be stepwise extended to other therapeutic areas as well as to widen the partnership with other European regions.
Laser activated gold pyramids could deliver drugs, DNA into cells without harm
24.03.2017 | Harvard John A. Paulson School of Engineering and Applied Sciences
What does congenital Zika syndrome look like?
24.03.2017 | University of California - San Diego
Astronomers from Bonn and Tautenburg in Thuringia (Germany) used the 100-m radio telescope at Effelsberg to observe several galaxy clusters. At the edges of these large accumulations of dark matter, stellar systems (galaxies), hot gas, and charged particles, they found magnetic fields that are exceptionally ordered over distances of many million light years. This makes them the most extended magnetic fields in the universe known so far.
The results will be published on March 22 in the journal „Astronomy & Astrophysics“.
Galaxy clusters are the largest gravitationally bound structures in the universe. With a typical extent of about 10 million light years, i.e. 100 times the...
Researchers at the Goethe University Frankfurt, together with partners from the University of Tübingen in Germany and Queen Mary University as well as Francis Crick Institute from London (UK) have developed a novel technology to decipher the secret ubiquitin code.
Ubiquitin is a small protein that can be linked to other cellular proteins, thereby controlling and modulating their functions. The attachment occurs in many...
In the eternal search for next generation high-efficiency solar cells and LEDs, scientists at Los Alamos National Laboratory and their partners are creating...
Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are less stable. Now researchers at the Technical University of Munich (TUM) have, for the first time ever, produced a composite material combining silicon nanosheets and a polymer that is both UV-resistant and easy to process. This brings the scientists a significant step closer to industrial applications like flexible displays and photosensors.
Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are...
Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to simulate these confined natural conditions in artificial vesicles for the first time. As reported in the academic journal Small, the results are offering better insight into the development of nanoreactors and artificial organelles.
Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to...
20.03.2017 | Event News
14.03.2017 | Event News
07.03.2017 | Event News
24.03.2017 | Materials Sciences
24.03.2017 | Physics and Astronomy
24.03.2017 | Physics and Astronomy